Grace Therapeutics, Inc. · NASDAQ:GRCE

Opaleye Management Inc. bought 11,608 Grace Therapeutics, Inc. shares (Form 4)

Traded Aug 14, 2026 · Filed Aug 19, 2026

On Aug 14, 2026, Opaleye Management Inc. (10% owner) bought 11,608 Grace Therapeutics, Inc. shares at US$2.09 for US$24,261, leaving 2,760,000 shares. Filed Aug 19, 2026 (Form 4).

Bought
11,608 shares
Price
US$2.09
Value
US$24,261
Holding after
2,760,000 shares (held indirectly)
Trading plan
No
Role
10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 14, 2026Common Stock, par value $0.0001 per shareBuy11,608US$2.092,760,000Indirect

Source

View original at SEC

Related